These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

440 related articles for article (PubMed ID: 25349065)

  • 1. Local paclitaxel induces late lumen enlargement in coronary arteries after balloon angioplasty.
    Kleber FX; Schulz A; Waliszewski M; Hauschild T; Böhm M; Dietz U; Cremers B; Scheller B; Clever YP
    Clin Res Cardiol; 2015 Mar; 104(3):217-25. PubMed ID: 25349065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography.
    Poerner TC; Duderstadt C; Goebel B; Kretzschmar D; Figulla HR; Otto S
    Clin Res Cardiol; 2017 Jan; 106(1):18-27. PubMed ID: 27379610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of Favorable Angiographic Outcomes After Drug-Coated Balloon Use for de novo Small Vessel Coronary Disease (DCB-ONLY).
    Kang WC; Park SM; Jang AY; Oh PC; Shin ES; Yu CW; Oh SJ; Kim YH; Won H; Lee SR; Lee SY; Hong YJ; Lee SY; Kim BO; Kim SW;
    Angiology; 2021 Nov; 72(10):986-993. PubMed ID: 33982603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Shin ES; Ann SH; Balbir Singh G; Lim KH; Kleber FX; Koo BK
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):193-200. PubMed ID: 26423017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-coated balloon in combination with bare metal stent for treatment of de novo coronary lesions: an optical coherence tomography first-in-human randomised trial, balloon first vs. stent first.
    Gutiérrez-Chico JL; van Geuns RJ; Koch KT; Koolen JJ; Duckers H; Regar E; Serruys PW
    EuroIntervention; 2011 Oct; 7(6):711-22. PubMed ID: 21986329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions.
    Chung JH; Shin ES; Her AY; Lee JM; Doh JH; Nam CW; Koo BK
    Int J Cardiovasc Imaging; 2020 Feb; 36(2):179-185. PubMed ID: 31598811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes After Treatment With a Paclitaxel-Coated Balloon Versus Balloon Angioplasty: Insights From the PEPCAD-DES Study (Treatment of Drug-eluting Stent [DES] In-Stent Restenosis With SeQuent Please Paclitaxel-Coated Percutaneous Transluminal Coronary Angioplasty [PTCA] Catheter).
    Rittger H; Waliszewski M; Brachmann J; Hohenforst-Schmidt W; Ohlow M; Brugger A; Thiele H; Birkemeyer R; Kurowski V; Schlundt C; Zimmermann S; Lonke S; von Cranach M; Markovic S; Daniel WG; Achenbach S; Wöhrle J
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1695-700. PubMed ID: 26476609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of a paclitaxel coated balloon in combination with a bare metal stent on restenosis and endothelial function: comparison with a drug eluting stent and a bare metal stent.
    Clever YP; Cremers B; Speck U; Dietz U; Böhm M; Scheller B
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):323-31. PubMed ID: 23996969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DANUBIO - a new drug-eluting balloon for the treatment of side branches in bifurcation lesions: six-month angiographic follow-up results of the DEBSIDE trial.
    Berland J; Lefèvre T; Brenot P; Fajadet J; Motreff P; Guerin P; Dupouy P; Schandrin C;
    EuroIntervention; 2015 Dec; 11(8):868-76. PubMed ID: 26696455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiographic performance of a novel sirolimus-coated balloon in native coronary lesions: the FAtebenefratelli SIrolimus COated NATIVES prospective registry.
    Cortese B; Pellegrini D; Latini RA; Di Palma G; Perotto A; Orrego PS
    J Cardiovasc Med (Hagerstown); 2019 Jul; 20(7):471-476. PubMed ID: 30994510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-coated balloon angioplasty with provisional stenting versus primary stenting for the treatment of de novo coronary artery lesions: REC-CAGEFREE I trial rationale and design.
    Gao C; He X; Liu Y; Liu J; Jiang Z; Zhu B; Qin X; Xia Y; Zhang T; Wang P; Zhang R; Onuma Y; Xia J; Wang D; Serruys P; Tao L
    BMC Cardiovasc Disord; 2024 Jun; 24(1):319. PubMed ID: 38914951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries.
    Wöhrle J; Werner GS
    Catheter Cardiovasc Interv; 2013 Apr; 81(5):793-9. PubMed ID: 22511572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular Ultrasound vs Angiography-Guided Drug-Coated Balloon Angioplasty: The ULTIMATE Ⅲ Trial.
    Gao XF; Ge Z; Kong XQ; Chen X; Han L; Qian XS; Zuo GF; Wang ZM; Wang J; Song JX; Lin L; Pan T; Ye F; Wang Y; Zhang JJ; Chen SL;
    JACC Cardiovasc Interv; 2024 Jul; 17(13):1519-1528. PubMed ID: 38842991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of bifurcation lesions with a drug-eluting balloon: the PEPCAD V (Paclitaxel Eluting PTCA Balloon in Coronary Artery Disease) trial.
    Mathey DG; Wendig I; Boxberger M; Bonaventura K; Kleber FX
    EuroIntervention; 2011 May; 7 Suppl K():K61-5. PubMed ID: 22027730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial.
    Kleber FX; Rittger H; Ludwig J; Schulz A; Mathey DG; Boxberger M; Degenhardt R; Scheller B; Strasser RH
    Clin Res Cardiol; 2016 Jul; 105(7):613-21. PubMed ID: 26768146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting balloon combined with paclitaxel-eluting balloon for treatment of in-stent restenosis.
    Kong J; Hou J; Ma L; Xing L; Jia H; Liu H; Zhang S; Yu B; Jang IK
    Arch Cardiovasc Dis; 2013 Feb; 106(2):79-85. PubMed ID: 23527911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative assessment of the antirestenotic efficacy of two paclitaxel drug-eluting balloons with different coatings in the treatment of in-stent restenosis.
    Nijhoff F; Stella PR; Troost MS; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Agostoni P
    Clin Res Cardiol; 2016 May; 105(5):401-11. PubMed ID: 26541146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel drug-coated scoring balloon for the treatment of coronary in-stent restenosis: Results from the multi-center randomized controlled PATENT-C first in human trial.
    Scheller B; Fontaine T; Mangner N; Hoffmann S; Bonaventura K; Clever YP; Chamie D; Costa R; Gershony G; Kelsch B; Kutschera M; Généreux P; Cremers B; Böhm M; Speck U; Abizaid A
    Catheter Cardiovasc Interv; 2016 Jul; 88(1):51-9. PubMed ID: 26331782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Drug-Coated Balloons in Native Coronary Artery Disease Left With a Dissection.
    Cortese B; Silva Orrego P; Agostoni P; Buccheri D; Piraino D; Andolina G; Seregni RG
    JACC Cardiovasc Interv; 2015 Dec; 8(15):2003-2009. PubMed ID: 26627997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.